MBX Biosciences, Inc. | LinkedIn (original) (raw)

Biotechnology Research

Carmel, IN 6,956 followers

Advancing potential breakthrough medicines for endocrine diseases of substantial medical need.

About us

MBX Biosciences, Inc. is a clinical stage biopharmaceutical company pioneering investigational Precision Endocrine Peptides (PEPs™). PEPs are designed to overcome key limitations of native peptide therapeutics to deliver superior pharmacologic properties. MBX is advancing a pipeline of PEP candidates to address the unmet needs of people with endocrine disorders. The company’s lead product candidate, MBX 2109 for the treatment of hypoparathyroidism, is currently in a Phase 1 clinical trial. Members of MBX’s leadership team have collaborated over several decades on the discovery, development, and commercialization of highly successful endocrine therapeutics including Forteo® and Humalog®. The company is supported by leading life science investors including Frazier Life Sciences, New Enterprise Associates and OrbiMed.

Industry

Biotechnology Research

Company size

11-50 employees

Headquarters

Carmel, IN

Type

Privately Held

Founded

2019

Locations

Employees at MBX Biosciences, Inc.

Updates

The last subject’s last visit is now complete in our Phase 1 trial of MBX 1416, a long-acting #GLP1 receptor antagonist in development for post-bariatric hypoglycemia (PBH). With no approved therapies for #PBH, this represents meaningful progress toward addressing an important unmet medical need for patients. Topline results from the trial are expected in early January 2025. We thank the participants, investigators, and clinical team for their contributions to this program. View more information in the press release: https://lnkd.in/ecmYTm4K
Our Chief Executive Officer and Co-Founder, Kent Hawryluk, will be participating in a fireside chat at the Stifel 2024 Healthcare Conference in New York on November 18 at 3:00 p.m. EST. We look forward to discussing the latest progress around our pipeline of #endocrine and #metabolic candidates and upcoming anticipated milestones. For those not attending, access the webcast and a replay at https://lnkd.in/g3mBBiBV
The MBX Biosciences team is excited to participate at the Guggenheim Inaugural Healthcare Innovation Conference in Boston today. Our team will be sharing insights during a fireside chat at 3:30 p.m. EST. Tune in to learn more about our precision peptide therapies for #endocrine and #metabolic disorders. View the live webcast and a replay at https://lnkd.in/g3mBBiBV
In celebration of STEM Day, we’re proud to highlight MBX Biosciences’ commitment to inspiring the next generation of innovators! Through our ongoing #STEM initiatives, we’re dedicated to sparking curiosity in science, technology, engineering, and math—investing in the leaders of tomorrow who will drive the future of healthcare and patient care. Join us in celebrating #STEMDay and the role STEM education plays in shaping a future of innovation and impact! #FutureLeaders #STEMCareers #STEMDay2024
6,956 followers
1w Edited
Tomorrow, our Scientific Co-Founder, Richard DiMarchi, Ph.D., will be a keystone speaker at the 2024 BioCrossroads Life Sciences Summit in Indianapolis, where he will share insights around the latest innovations shaping #diabetes and #obesity care. Our Senior Vice President, Discovery & Non-Clinical Development, Michael A. Dorato, PhD, DABT, Fellow ATS, FRSB will also be joining Ruth Gimeno, Ph.D., and Karen Wurster, MBA, for a panel discussion moderated by Dr. Janel Gordon, MD, DipABOM, DipABLM, exploring next generation approaches to diabetes and obesity management. Don’t miss this opportunity to learn more about recent breakthroughs and forward-looking insights surrounding these #metabolic conditions. Register for the event here: https://bit.ly/3zPzRPA
MBX Biosciences, Inc. reposted this
Our Chief Medical Officer, Salomon (Sam) Azoulay, M.D., attended the HypoPARAthyroidism Association’s International HypoPARAthyroidism Conference this past weekend to share an overview of the Company and MBX-2109, our potential long-acting parathyroid hormone (PTH) peptide prodrug for the treatment of #hypoparathyroidism. Check out photos from the conference where we shared how we’re working to redefine patient outcomes and enhance the quality of life for hypoparathyroidism patients everywhere.#endocrine
Our Chief Medical Officer, Salomon (Sam) Azoulay, M.D., attended the HypoPARAthyroidism Association’s International HypoPARAthyroidism Conference this past weekend to share an overview of the Company and MBX-2109, our potential long-acting parathyroid hormone (PTH) peptide prodrug for the treatment of #hypoparathyroidism. Check out photos from the conference where we shared how we’re working to redefine patient outcomes and enhance the quality of life for hypoparathyroidism patients everywhere.#endocrine
Last week, we held a company-wide virtual meeting with Patty Keating, Executive Director, and Michele Rayes, Associate Director, of the HypoPARAthyroidism Association. Patty and Michele shared invaluable insights into the daily realities of living with #hypoparathyroidism. Their perspectives underscored the importance of our work and deepened our commitment to making a difference for patients impacted by this challenging condition. At MBX, our mission is to help people with #endocrine and #metabolic disorders live fuller and healthier lives. Learn more about MBX and explore opportunities to join us in pursuit of this mission by visiting our LinkedIn Careers page: https://bit.ly/3C8NcDc
The MBX team is participating in three investor conferences this November, including the Guggenheim Inaugural Healthcare Innovation Conference, the Stifel Healthcare Conference and the Jefferies London Healthcare Conference. View full details below and access the live webcasts and replays on our IR site. https://lnkd.in/ebwYDuWq #JefferiesHealthcare

Join now to see what you are missing

Join now

MBX Biosciences, Inc. | LinkedIn (original) (raw)

Biotechnology Research

Carmel, IN 6,956 followers

Advancing potential breakthrough medicines for endocrine diseases of substantial medical need.

About us

Locations

Employees at MBX Biosciences, Inc.

Updates

Join now to see what you are missing

Similar pages

Browse jobs

Funding